Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SN vs GSK✓SelectedUSD · GSKSN vs GSK performance historyLatest closeAs of-1.37%11/16
Stock and ETF performance explorer

SN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+440.3%
GSK return
+62.5%
Excess return
+377.8%
Maximum drawdown
-42.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.4%-0.1%-1.3%-1.4%
7D-2.7%-1.3%-1.4%-2.5%
30D+19.7%+2.7%+17.0%+19.3%
3M+20.6%+2.7%+17.9%+20.0%
6M+111.4%+3.3%+108.1%+110.1%
YTD+99.5%+6.5%+93.1%+98.6%
1Y+153.6%+10.7%+143.0%+151.8%
3Y+419.8%+64.4%+355.4%+344.0%
All+440.3%+62.5%+377.8%+363.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling